Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
(NQ: )
N/A   UNCHANGED
Last Price  /  Updated:   /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 0
Open -
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close -
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding N/A
Dividend Yield N/A
Performance
Top News
More News
Tobira Therapeutics Completes Financing and Merger with Regado Biosciences
Newly NASDAQ-Listed TBRA Has Approximately $70 Million to Complete NASH Phase 2b Study and Build Multi-Indication Platform with Cenicriviroc Read More
from PR Newswire
Tobira Therapeutics Highlights Presentations at The International Liver Congress 2015
from PR Newswire
More News
Read More
Tobira Therapeutics Highlights Presentations at the AASLD's Industry Colloquium for Novel Targets and Therapies in Liver Disease
from PR Newswire
Tobira Therapeutics Closes Financing to Support Development of CVC in Non-Alcoholic Steatohepatitis
from PR Newswire
Tobira Therapeutics Doses First Subject in Phase 1 Clinical Trial of Cenicriviroc and Pioglitazone
from PR Newswire
REMINDER: Regado Biosciences and Tobira Therapeutics Merger Agreement Conference Call Set for 8:30 a.m. EST Today, Jan. 20
from PR Newswire
Regado Biosciences and Tobira Therapeutics Announce Merger Agreement to Create Leading NASH Company
from PR Newswire
Durable goods orders plunge, markets collapse
category Market News
from MarketMinute.com Market Updates
Regado Biosciences Announces Third Quarter 2014 Financial Results and Provides Corporate Update
from PR Newswire
Regado Biosciences to Provide Third Quarter 2014 Financial Results
from PR Newswire
Regado Biosciences Appoints Michael A. Metzger CEO
from PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.